The S&P/ASX 200 Index (ASX: XJO) is down 0.7% in early afternoon trade on Thursday, but that's not keeping these four ASX 200 shares from leaping to new 52-week highs.
Two of the outperforming companies operate in the healthcare space, one is a national insurer, and the fourth operates Australia's biggest airline.
(You can probably guess that last one.)
Here's what's happening.
The first ASX 200 share notching new 52-week plus highs today despite the slumping market is QBE Insurance Group Ltd (ASX: QBE).
Shares in the insurance giant are up 1.0% at the time of writing, trading for $20.35 after touching a high of $20.40. That puts the QBE share price up 29.5% since this time last year, its highest level since May 2010.
Atop the strong run over the last year, QBE shares also trade on a partly franked 3.5% trailing dividend yield.
Also marching into new 52-week high territory today is ASX 200 share Pro Medicus Ltd (ASX: PME).
Shares in the health imaging company are currently flat at 268.08 after hitting a milestone high of $272.50 in early trade today. That's not only a new one-year high, but a new all-time high for the Pro Medicus share price and sees the Pro Medicus share price up 165% in 52 weeks.
Pro Medicus shares also trade on a slender, fully franked 0.2% trailing dividend yield.
Which brings us to the third ASX 200 share hitting new 52-week plus highs today amid the wider market retrace, Qantas Airways Ltd (ASX: QAN).
Shares in the Flying Kangaroo are up 1.3% in early afternoon trade today, at $9.50 after touching a high of $9.54 around midday. That puts the Qantas share price up 76.9% over the past full year. And in a sign that Qantas has truly flown past its pandemic stock meltdown and post-pandemic reopening hiccups, this also marks a new all-time high for the airline.
Qantas has yet to reinstate dividends, which were suspended in 2020. But 2025 could see Qantas dividends make a comeback. The airline has been benefiting from the ongoing rebound in domestic and international travel demand, along with lower-than-expected jet fuel costs in 2024.
Moving on to the fourth ASX 200 share hitting 52-week highs today, we have Telix Pharmaceuticals Ltd (ASX: TLX).
Shares in the diagnostic and therapeutic product developer are up 0.2% at the time of writing at $26.88 each. This puts the Telix share price up 141.1% in 12 months.
In earlier trading today, the Telix share price climbed to a fresh high of $27.29. And like Qantas and Pro Medicus, this means Telix shares have traded at an all-time high today.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.